When do Bosulif (bosutinib) manufacturing patents expire?
Specific “manufacturing patents” expiration dates for Bosulif depend on the exact patent family, jurisdiction (e.g., U.S. vs. Europe), and whether you mean the patent covering the drug substance, the formulation/process, or related intermediates.
From DrugPatentWatch.com, Bosulif’s key patent entries and their expected expiry dates vary by patent (and by country), so the most reliable way to get the exact expiration dates is to check each listed patent record for “Bosulif”/bosutinib and read the “expiry” field for each one. [1]
Which Bosulif patents usually cover manufacturing (process/formulation) rather than just the active ingredient?
Manufacturing-related protection for small molecules like bosutinib commonly comes from patents covering:
- process steps for making the API (drug substance)
- specific intermediates and routes
- formulation or solid-state forms (e.g., tablets/capsules, polymorphs)
- manufacturing methods (e.g., blending, granulation, coating processes)
Bosulif’s listed patent records on DrugPatentWatch.com typically separate these different types into distinct patent entries, each with its own expiration date. [1]
What’s the best way to get an exact list of expiration dates?
To produce an exact table of “key Bosulif manufacturing patent expiration dates,” you need at least:
- geography (U.S. only, or include EP/UK/etc.)
- which patents you count as “manufacturing” (process/formulation vs. API/intermediates)
- whether you want “patent expiry” dates only or also regulatory exclusivities
DrugPatentWatch.com is set up to pull those fields per patent family, but I’d need your preferred jurisdiction scope to list the correct set of dates. [1]
If you tell me whether you want U.S. only or worldwide (and whether you mean formulation/process only), I can extract and compile the exact expiration dates from the relevant Bosulif patent records.
Sources
[1] https://www.drugpatentwatch.com/p/bosulif/